$76.20-1.31 (-1.69%)
Blue Bird Corporation, together with its subsidiaries, designs, engineers, manufactures, and sells school buses in the United States, Canada, and internationally.
Blue Bird Corporation in the Industrials sector is trading at $76.20 with a market capitalization of $2.4B. Wall Street consensus targets $84.50 (8 analysts), implying a +10.9% move over the next 12 months. The stock is currently near its 52-week high of $83.39, remaining 27.4% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $352.63M↑ | $333.08M↓ | $409.37M↑ | $398.01M↑ | $358.85M |
| Gross Profit | $70.65M↓ | $71.23M↓ | $86.41M↑ | $85.93M↑ | $70.85M |
| Operating Income | $39.12M↑ | $37.68M↓ | $50.34M↑ | $50.07M↑ | $33.71M |
| Net Income | $29.30M↓ | $30.76M↓ | $36.50M↑ | $36.45M↑ | $26.05M |
Blue Bird Corporation, together with its subsidiaries, designs, engineers, manufactures, and sells school buses in the United States, Canada, and internationally. The company operates through two segments, Bus and Parts. It offers Type C, Type D, and...
Blue Bird (BLBD) closed the most recent trading day at $80.2, moving 1.33% from the previous trading session.
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
Check out the companies making headlines yesterday:
Shares of school bus company Blue Bird (NASDAQ:BLBD) jumped 4% in the afternoon session after Barclays lifted its price target on the stock to $85 from $75 while reiterating an Overweight rating. The analyst note was tied to a broader reset of machinery and construction forecasts ahead of the second quarter. Barclays argued that production trends, new awards, firm pricing, and ongoing acquisitions supported a solid outlook into 2026. Furthermore, Blue Bird's strong cash generation and healthier
Barclays raised Blue Bird’s price target to $85, adding that the group remains investable, while JPMorgan raised its price target on Anterix to $133 from $50 while maintaining an ‘Overweight’ rating.